Amol Akhade, Senior Consultant at Fortis Hospitals Mumbai, shared a post on X:
“Carboplatin for early stage TNBC.
All trials in one slide . It should be given to those who don’t have acess to IO . Those who can receive IO , further question is, if it can reduce anthracycline use .
Good discussion.”
More posts featuring Amol Akhade on OncoDaily.
